Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

CYPROMAX

Class 5Status: Abandoned
Application Number1013223
Trademark Status
Abandoned
Trademark Class5
Application Date2001-05-31
Proprietor NameASHOK ROOPCHAND PANJWANI
Appropriate OfficeMUMBAI
StateMAHARASHTRA
Trademark TypeWORD
User Details01/04/2001
Agent NameINTERNATIONAL TRADE MARKS BUREAU.[285]
Agent Address1ST FLOOR, MANEKJI WADIA BUILDING, 127, M.G. ROAD, FORT MUMBAI - 400 001.
Goods And Services Details[CLASS : 5] MEDICINAL AND PHARAMACEUTICAL PREPARATIONS AND AUBSTANCES IN CLASS 5

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
CYPROMAX5Abandoned
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about CYPROMAX.

What is the status of trademark application 1013223?
The current status of trademark application 1013223 for CYPROMAX is Abandoned.
What is the trademark class of CYPROMAX?
CYPROMAX is registered under trademark class 5.
Who is the proprietor of CYPROMAX?
The proprietor of CYPROMAX is ASHOK ROOPCHAND PANJWANI.
When was trademark application 1013223 filed?
Trademark application 1013223 for CYPROMAX was filed on 2001-05-31.